To understand the influenza vaccination rates and factors associated with vaccination behavior of urban elder people in China. We performed a cross-sectional questionnaire study recruiting urban elder people from six cities in China between 9 December and 30 December 2024 in community. Demographics, knowledge about influenza, vaccination status, intention and reasons to receive or not receive the vaccine, and planning to be re-vaccinated were analyzed. Continuous and categorical variables were compared using unpaired z-test and Chi-square test, respectively. Potential confounders were adjusted using multiple logistic regression. 13363 urban elder people participated, with a mean age of 70 years, of which 54.7% were female, 15.4% in Chengdu, 16.3% of were in Beijing, 16.0% in Qingdao, 16.5% in Hangzhou, 16.9% in Shenzhen and 18.9% in Chongqing. The primary chronic conditions included hypertension, diabetes, hyperlipidemia, and stroke. The overall awareness rate of the influenza vaccine was 78.6%. Of the aware population, 40.3% received the vaccination and 78.8% were willing to be re-vaccinated. The overall vaccination rate was 34.0%, and 80.3 % were willing to be re-vaccinated. Higher education level (OR 1.40), higher income level (OR 1.52), marriage (OR 1.71), having health insurance (OR 1.72), having poor self-care ability (OR 1.30), having comorbidities (OR 1.18) were independently associated with influenza vaccination among older adults. Misconception of influenza, conformity with unvaccinated family or friends, and effectiveness and safety concerns of influenza vaccine were main barriers to influenza vaccination. The Government should improve influenza vaccination acceptance among elderly people through public education using diverse channels.

The authors have declared no competing interest.

the Beijing Natural Science Foundation (BNSF)

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

the Institutional Review Board of the Chinese Academy of Medical Sciences & Peking Union Medical College

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors